
CBSA to honor life science innovators, leaders tonight
DENVER -- Colorado BioScience Association (CBSA) will highlight a banner year marked by acquisitions, investments, discoveries and partnerships during its 14 th Annual Awards Dinner tonight in... Read More
Thursday November 9, 2017

miRagen Therapeutics completes merger with Signal Genetics, raises $40.7M in equity financing
BOULDER -- Miragen Therapeutics, Inc. (Nasdaq: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, announced its merger with... Read More
Monday February 20, 2017

MiRagen Therapeutics, Signal Genetics sign merger agreement
BOULDER --Miragen Therapeutics and California-based Signal Genetics, Inc. (Nasdaq: SGNL) today announced they have entered into a definitive merger agreement in which the stockholders of miRagen... Read More
Tuesday November 1, 2016
.jpg)
CBSA: 2015 was groundbreaking year for life sciences industry
DENVER -- Colorados life sciences sector had a robust and groundbreaking 2015, according to the Colorado BioScience Association (CBSA), the states advocate for the industry. CBSA reported... Read More
Wednesday December 16, 2015

miRagen Therapeutics raises $41M in Series C fundraising round
BOULDER -- miRagen Therapeutics , a biopharmaceutical company developing innovative microRNA-based therapeutics, announced a Series C preferred stock financing with gross proceeds of $41 million,... Read More
Wednesday November 11, 2015

miRagen Therapeutics and Santaris Pharma expand global alliance for microRNA drug discovery
BOULDER - miRagen Therapeutics and Denmark-based Santaris Pharma A/S announced they are expanding an existing partnership to discover and produce drugs to treat more diseases caused by... Read More
Thursday January 10, 2013

miRagen Therapeutics named to FierceBiotech's Fierce 15 List of most promising biotech firms
BOULDER - FierceBiotech has named miRagen Therapeutics one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. "Over the past... Read More
Thursday September 20, 2012